NeuroPace to Present at the 43rd Annual J.P. Morgan Healthcare Conference
NeuroPace (NPCE), a medical device company specializing in epilepsy treatment solutions, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. The company's management team will deliver a presentation on January 15, 2025, at 4:30 PM PT (7:30 PM ET) in San Francisco, CA.
In addition to the presentation, the management team will engage in investor meetings throughout the conference. Interested parties can access the presentation through a live webcast, and a replay will remain available for two weeks following the event on the Events section of NeuroPace's Investor website.
NeuroPace (NPCE), un'azienda di dispositivi medici specializzata nelle soluzioni per il trattamento dell'epilessia, ha annunciato la sua partecipazione al 43° Annuale J.P. Morgan Healthcare Conference. Il team di gestione dell'azienda presenterà il 15 gennaio 2025, alle 16:30 PT (19:30 ET) a San Francisco, CA.
Oltre alla presentazione, il team di gestione parteciperà a riunioni con gli investitori durante tutto il convegno. Le parti interessate possono accedere alla presentazione tramite una diretta streaming, e una registrazione sarà disponibile per due settimane dopo l'evento nella sezione Eventi del sito web per investitori di NeuroPace.
NeuroPace (NPCE), una empresa de dispositivos médicos especializada en soluciones para el tratamiento de la epilepsia, ha anunciado su participación en la 43ª Conferencia Anual de Atención Médica de J.P. Morgan. El equipo de gestión de la empresa realizará una presentación el 15 de enero de 2025, a las 4:30 PM PT (7:30 PM ET) en San Francisco, CA.
Además de la presentación, el equipo de gestión participará en reuniones con inversores a lo largo de la conferencia. Las partes interesadas pueden acceder a la presentación a través de una transmisión en vivo, y una repetición estará disponible durante dos semanas después del evento en la sección de Eventos del sitio web de inversores de NeuroPace.
NeuroPace (NPCE)는 간질 치료 솔루션을 전문으로 하는 의료 기기 회사로, 제43회 연례 J.P. Morgan 헬스케어 컨퍼런스에 참가한다고 발표했습니다. 회사의 경영팀은 2025년 1월 15일 오후 4시 30분 PT (오후 7시 30분 ET)에 샌프란시스코, CA에서 발표를 진행할 예정입니다.
발표 외에도 경영팀은 컨퍼런스 기간 동안 투자자 회의에 참여할 것입니다. 관심 있는 경우, 라이브 웹캐스트를 통해 발표에 접근할 수 있으며, 이벤트의 투자자 웹사이트 '이벤트' 섹션에서 이벤트 후 2주간 다시보기 서비스를 이용할 수 있습니다.
NeuroPace (NPCE), une entreprise de dispositifs médicaux spécialisée dans les solutions de traitement de l'épilepsie, a annoncé sa participation à la 43e Conférence Annuelle de Santé de J.P. Morgan. L'équipe de direction de l'entreprise présentera le 15 janvier 2025, à 16h30 PT (19h30 ET) à San Francisco, CA.
En plus de la présentation, l'équipe de direction participera à des réunions avec des investisseurs tout au long de la conférence. Les parties intéressées peuvent accéder à la présentation via une diffusion en direct, et une rediffusion sera disponible pendant deux semaines après l'événement dans la section Événements du site Web des investisseurs de NeuroPace.
NeuroPace (NPCE), ein Unternehmen für medizinische Geräte, das sich auf Lösungen zur Behandlung von Epilepsie spezialisiert hat, hat seine Teilnahme an der 43. J.P. Morgan Healthcare Conference bekannt gegeben. Das Managementteam des Unternehmens wird am 15. Januar 2025 um 16:30 Uhr PT (19:30 Uhr ET) in San Francisco, CA eine Präsentation halten.
Zusätzlich zur Präsentation wird das Managementteam während der gesamten Konferenz an Investorenbesprechungen teilnehmen. Interessierte können die Präsentation über einen Live-Stream verfolgen, und eine Wiederholung wird zwei Wochen nach der Veranstaltung im Bereich 'Veranstaltungen' der Investorenseite von NeuroPace verfügbar sein.
- None.
- None.
MOUNTAIN VIEW, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that its management team will present at the 43rd Annual J.P. Morgan Healthcare Conference at 4:30pm PT (7:30pm ET) on Wednesday, January 15, 2025, in San Francisco, CA. Management will also host investor meetings during the conference.
The presentation will be accessible via live webcast here. A webcast replay will be available for two weeks following the presentation in the Events section of NeuroPace’s Investor website at https://investors.neuropace.com.
About NeuroPace, Inc.
Based in Mountain View, Calif., NeuroPace is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is the first and only commercially available, brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients living with drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders.
Investor Contact:
Jeremy Feffer
Managing Director
LifeSci Advisors
jfeffer@lifesciadvisors.com
FAQ
When is NeuroPace (NPCE) presenting at the JP Morgan Healthcare Conference 2025?
How can investors watch NeuroPace's presentation at the JP Morgan Healthcare Conference?
Will NeuroPace (NPCE) management be available for investor meetings at the conference?
How long will the replay of NeuroPace's JP Morgan Conference presentation be available?
